Description
The study identifies a striking female-specific upregulation of complement components (C1QA, C1QC) and kininogen (KNG1) but provides no mechanistic explanation for this sex-dimorphic neuroimmune response. Understanding these upstream regulatory mechanisms is critical for developing sex-stratified therapeutic approaches.
Gap type: unexplained_observation Source paper: Phosphoproteomics uncovers a neuroimmune perspective on trigeminal neuralgia: sexually dimorphic regulatory networks linking calcium channels to the complement cascade. (2026, Frontiers in immunology, PMID:41853292)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:26.119235+00:00”, “resolution_summary”: “Resolved by hypothesis h-16591043d1: Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recogniti. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc_task_73907230.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-16591043d1”, “title”: “Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition functions”, “score”: 0.348, “reason”: “5 token overlaps; entity overlap: c1qa, c1qc”, “analysis_id”: “SDA-2026-04-25-gapdebate-afba1a80bd”, “target_gene”: “C1QA,C1QB,C1QC,C1R,C1S,C4A,C4B,C3”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.75, “confidence_score”: 0.74, “status”: “proposed”, “pubmed_evidence_ids”: [“18083105”, “27033548”, “27114033”, “27337340”, “36600274”]}, {“id”: “h-85b51a8f58”, “title”: “Microglial TREM2 state determines whether C1q-tagged substrates are cleared adaptively or converted into chronic complement-associated synaptotoxic inflammation”, “score”: 0.346, “reason”: “5 token overlaps; entity overlap: c1qa, c1qc”, “analysis_id”: “SDA-2026-04-25-gapdebate-afba1a80bd”, “target_gene”: “TREM2,TYROBP,C1QA,C1QB,C1QC,C3”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.67, “confidence_score”: 0.71, “status”: “proposed”, “pubmed_evidence_ids”: [“28602351”, “32579671”, “33516818”, “36306735”, “37442133”]}, {“id”: “h-1ac3dd5b75”, “title”: “C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macrophages”, “score”: 0.334, “reason”: “17 token overlaps; entity overlap: c1qa, c1qc”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc”, “target_gene”: “C1QA/C1QC”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.631065, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“19370150”, “20393552”, “28903622”, “30396994”]}, {“id”: “h-fa83846f7d”, “title”: “Microglia and complement sustain post-Aβ neurodegeneration after tau missorting is established”, “score”: 0.333, “reason”: “4 token overlaps; entity overlap: c1qa, c1qc”, “analysis_id”: “SDA-2026-04-25-gapdebate-98a600b3ed”, “target_gene”: “C1QA,C1QB,C1QC,C3,ITGAM,TREM2,TYROBP”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.69, “confidence_score”: 0.76, “status”: “proposed”, “pubmed_evidence_ids”: [“10471215”, “26544197”, “27114033”, “29563239”, “31601677”]}, {“id”: “h-ae924ee8”, “title”: “C1q Inhibition Prevents Synaptic Mitochondrial Dysfunction via Microglial-Neuronal Cross-Talk Normalization”, “score”: 0.331, “reason”: “18 token overlaps; entity overlap: c1qa, c1qc”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-082509-118fcb37”, “target_gene”: “C1QA/C1QB/C1QC”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.455, “confidence_score”: 0.5, “status”: “proposed”, “pubmed_evidence_ids”: [“27033548”, “37679434”, “computational”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc_task_73907230”, “title”: “While the study establishes C1QA and C1QC as diagnostic biomarkers and confirms their association with atherosclerosis risk, the mechanistic pathways linking complement activation to plaque pathogenesis remain unexplained. Understanding these mechanisms is critical since atherosclerosis is a major cause of vascular dementia and stroke-related neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis. (2023, Front Immunol, PMID:38179058)”, “score”: 0.617, “reason”: “12 token overlaps; entity overlap: c1qa, c1qc, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc”, “quality_score”: 0.706, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137”, “title”: “The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Understanding this mechanism is critical for developing therapeutic strategies that could mimic R136S protection.\n\nGap type: unexplained_observation\nSource paper: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. (2023, Nature neuroscience, PMID:37957317)”, “score”: 0.436, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145531-5c4e7b59_20260414-005547”, “title”: “The abstract reports extraordinary dopamine increases (>500-fold in drug-free patients) but provides no mechanistic explanation for how Atremorine achieves this effect. Understanding these mechanisms is critical for optimizing therapeutic applications and predicting safety profiles.\n\nGap type: unexplained_observation\nSource paper: Atremorine in Parkinson’s disease: From dopaminergic neuroprotection to pharmacogenomics. (2021, Med Res Rev, PMID:34106485)”, “score”: 0.434, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145531-5c4e7b59”, “quality_score”: 0.67, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041439-306c2cdb_task_73907230”, “title”: “The abstract describes IBA1 low/negative microglia in individuals with liver disease but provides no mechanistic explanation for this phenomenon. This represents an unexplored brain-liver axis that could impact neuroinflammation and neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: Beyond Activation: Characterizing Microglial Functional Phenotypes. (2021, Cells, PMID:34571885)”, “score”: 0.423, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041439-306c2cdb”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.423, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}